Status:
ACTIVE_NOT_RECRUITING
Amulet™ ADVANCE LAA
Lead Sponsor:
Abbott Medical Devices
Conditions:
Atrial Fibrillation
Stroke
Eligibility:
All Genders
18+ years
Brief Summary
This is a prospective, multicenter, observational study intended to characterize real-world outcomes on the commercially available Amulet device in the United States. Over 600 subjects have been enrol...
Detailed Description
The ADVANCE LAA study is intended to characterize real-world outcomes of patients receiving the commercially available Amulet device in the United States. The Amulet device is intended to reduce the r...
Eligibility Criteria
Inclusion
- Intended for LAAO with the Amulet device
- At least 18 years of age
- Willing and capable of providing informed consent and participating in all testing associated with this clinical study
Exclusion
- Presence of other conditions that, in the investigator's opinion, could limit the subject's ability to participate in follow-up
Key Trial Info
Start Date :
July 12 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2027
Estimated Enrollment :
610 Patients enrolled
Trial Details
Trial ID
NCT05997446
Start Date
July 12 2023
End Date
June 1 2027
Last Update
October 1 2025
Active Locations (16)
Enter a location and click search to find clinical trials sorted by distance.
1
Arizona Arrhythmia Research
Phoenix, Arizona, United States, 85016
2
Arkansas Heart Hospital
Little Rock, Arkansas, United States, 72211
3
Baptist Medical Center
Jacksonville, Florida, United States, 32207
4
Usman R. Siddiqui, MD
Winter Park, Florida, United States, 32792